CHINA TRAVEL INTL/ HK0308001558 /
| 2024-05-14 8:20:01 AM | Chg. -0.0040 | Volume | Bid11:47:24 AM | Ask12:38:48 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.1470EUR | -2.65% | 0 Turnover: 0.0000 |
0.1470Bid Size: 13,478 | 0.1620Ask Size: 12,500 | 0.1470 | 0.1470 |
GlobeNewswire
1:30 PM
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
1:30 PM
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
1:30 PM
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
1:30 PM
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
1:30 PM
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
1:30 PM
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
1:30 PM
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
1:30 PM
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
1:30 PM
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
GlobeNewswire
1:30 PM
Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
GlobeNewswire
1:30 PM
nCino Announces Timing of its First Quarter Fiscal Year 2025 Financial Results Conference Call
